PhotosBiographyFacebookTwitter

From Wikipedia, the free encyclopedia
Fakhreddin Jamali
Born (1945-05-31) May 31, 1945 (age 79)
Education University of British Columbia (PhD)
University of Tehran (Pharm.D.)
Known forfounding the Canadian Society for Pharmaceutical Sciences
Spouse(s)Elaheh Keshavarz-Jamali, PharmD, PhD (b. 1945- d. 2020) [1]
ChildrenVafa Jamali [1]
Awards Alberta Centennial Medal, AAPS fellowship, CSPS fellowship, Killam Professorship
Scientific career
Fields pharmaceutical sciences
Institutions University of Alberta

Fakhreddin Jamali (born May 31, 1945) is an Iranian-Canadian professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta. He is the founding president of the Canadian Society for Pharmaceutical Sciences, [2] and the editor-in-chief of Journal of Pharmacy and Pharmaceutical Sciences. [3]

Early life

Fakhreddin was born May 31, 1945, in Arak, Iran to Jamaleddin Jamali and Batoul Rouhani-Jamali. [4] [5]

Career

Jamali's focus has been on drugs action ( pharmacodynamics) and disposition ( pharmacokinetics) particularly in field of analgesics and antiinfammatory therapy. His earlier work on the stereoselective and stereospecific therapeutic and toxicity of drugs received high peer recognition. [6] He also reported that pain and/or its trauma delays absorption of drugs which may render them ineffective. [7] This is particularly important when a quick action is desired such as pain relief. His group found that inflammatory conditions such as arthritis diminish response to some cardiovascular drugs despite already known increased circulatory concentrations. [8] His group also has reported the mechanism behind the adverse cardiovascular effects of both anti-inflammatory drugs and inflammatory conditions. [9] [10] Jamali has received many national and international awards for his contribution to science and public wellbeing. [11]

References

  1. ^ a b "Dr. Fakhreddin Jamali: Pharmacist, Pharmaceutical Scientist and Mentor".
  2. ^ "2018 Board of Directors". Cspscanada.org. Retrieved 17 January 2019.
  3. ^ "Editorial Team". Journals.library.ualberta.ca. Retrieved 12 August 2018.
  4. ^ "سخنرانی دکتر فخرالدین جمالی در دانشکده داروسازی". Tehran University of Medical Sciences. Retrieved 26 January 2019.
  5. ^ "کانون سردفتران و دفتریاران". www.notary.ir. Retrieved 26 January 2019.
  6. ^ Jamali, F.; Mehvar, R.; Pasutto, F. M. (1 September 1989). "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls". Journal of Pharmaceutical Sciences. 78 (9): 695–715. doi: 10.1002/jps.2600780902. ISSN  0022-3549. PMID  2685226.
  7. ^ Jamali, Fakhreddin; Kunz-Dober, Cornelia M. (April 1999). "Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery: Pain-mediated altered absorption of ibuprofen". British Journal of Clinical Pharmacology. 47 (4): 391–396. doi: 10.1046/j.1365-2125.1999.00902.x. PMC  2014238. PMID  10233203.
  8. ^ Abdallah, Yasmeen El Hajj; Chahal, Sukhman; Jamali, Fakhreddin; Mahmoud, Sherif Hanafy (2023). "Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition". Journal of Pharmacy & Pharmaceutical Sciences. 26: 11137. doi: 10.3389/jpps.2023.11137. ISSN  1482-1826. PMC  9990632. PMID  36942294.
  9. ^ Aghazadeh-Habashi, Ali; Asghar, Waheed; Jamali, Fakhreddin (1 February 2018). "Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid". Journal of Pharmaceutical Sciences. 107 (2): 756–763. doi: 10.1016/j.xphs.2017.09.020. ISSN  0022-3549. PMID  28989019.
  10. ^ Asghar, Waheed; Aghazadeh-Habashi, Ali; Jamali, Fakhreddin (1 October 2017). "Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis". Inflammopharmacology. 25 (5): 543–553. doi: 10.1007/s10787-017-0344-1. ISSN  1568-5608. PMID  28389995. S2CID  254576802.
  11. ^ "Fakhreddin Jamali". International Pharmaceutical Federation.

External links


From Wikipedia, the free encyclopedia
Fakhreddin Jamali
Born (1945-05-31) May 31, 1945 (age 79)
Education University of British Columbia (PhD)
University of Tehran (Pharm.D.)
Known forfounding the Canadian Society for Pharmaceutical Sciences
Spouse(s)Elaheh Keshavarz-Jamali, PharmD, PhD (b. 1945- d. 2020) [1]
ChildrenVafa Jamali [1]
Awards Alberta Centennial Medal, AAPS fellowship, CSPS fellowship, Killam Professorship
Scientific career
Fields pharmaceutical sciences
Institutions University of Alberta

Fakhreddin Jamali (born May 31, 1945) is an Iranian-Canadian professor emeritus of pharmacy and pharmaceutical sciences at the University of Alberta. He is the founding president of the Canadian Society for Pharmaceutical Sciences, [2] and the editor-in-chief of Journal of Pharmacy and Pharmaceutical Sciences. [3]

Early life

Fakhreddin was born May 31, 1945, in Arak, Iran to Jamaleddin Jamali and Batoul Rouhani-Jamali. [4] [5]

Career

Jamali's focus has been on drugs action ( pharmacodynamics) and disposition ( pharmacokinetics) particularly in field of analgesics and antiinfammatory therapy. His earlier work on the stereoselective and stereospecific therapeutic and toxicity of drugs received high peer recognition. [6] He also reported that pain and/or its trauma delays absorption of drugs which may render them ineffective. [7] This is particularly important when a quick action is desired such as pain relief. His group found that inflammatory conditions such as arthritis diminish response to some cardiovascular drugs despite already known increased circulatory concentrations. [8] His group also has reported the mechanism behind the adverse cardiovascular effects of both anti-inflammatory drugs and inflammatory conditions. [9] [10] Jamali has received many national and international awards for his contribution to science and public wellbeing. [11]

References

  1. ^ a b "Dr. Fakhreddin Jamali: Pharmacist, Pharmaceutical Scientist and Mentor".
  2. ^ "2018 Board of Directors". Cspscanada.org. Retrieved 17 January 2019.
  3. ^ "Editorial Team". Journals.library.ualberta.ca. Retrieved 12 August 2018.
  4. ^ "سخنرانی دکتر فخرالدین جمالی در دانشکده داروسازی". Tehran University of Medical Sciences. Retrieved 26 January 2019.
  5. ^ "کانون سردفتران و دفتریاران". www.notary.ir. Retrieved 26 January 2019.
  6. ^ Jamali, F.; Mehvar, R.; Pasutto, F. M. (1 September 1989). "Enantioselective Aspects of Drug Action and Disposition: Therapeutic Pitfalls". Journal of Pharmaceutical Sciences. 78 (9): 695–715. doi: 10.1002/jps.2600780902. ISSN  0022-3549. PMID  2685226.
  7. ^ Jamali, Fakhreddin; Kunz-Dober, Cornelia M. (April 1999). "Pain-mediated altered absorption and metabolism of ibuprofen: an explanation for decreased serum enantiomer concentration after dental surgery: Pain-mediated altered absorption of ibuprofen". British Journal of Clinical Pharmacology. 47 (4): 391–396. doi: 10.1046/j.1365-2125.1999.00902.x. PMC  2014238. PMID  10233203.
  8. ^ Abdallah, Yasmeen El Hajj; Chahal, Sukhman; Jamali, Fakhreddin; Mahmoud, Sherif Hanafy (2023). "Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition". Journal of Pharmacy & Pharmaceutical Sciences. 26: 11137. doi: 10.3389/jpps.2023.11137. ISSN  1482-1826. PMC  9990632. PMID  36942294.
  9. ^ Aghazadeh-Habashi, Ali; Asghar, Waheed; Jamali, Fakhreddin (1 February 2018). "Drug-Disease Interaction: Effect of Inflammation and Nonsteroidal Anti-Inflammatory Drugs on Cytochrome P450 Metabolites of Arachidonic Acid". Journal of Pharmaceutical Sciences. 107 (2): 756–763. doi: 10.1016/j.xphs.2017.09.020. ISSN  0022-3549. PMID  28989019.
  10. ^ Asghar, Waheed; Aghazadeh-Habashi, Ali; Jamali, Fakhreddin (1 October 2017). "Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin–angiotensin system in experimental arthritis". Inflammopharmacology. 25 (5): 543–553. doi: 10.1007/s10787-017-0344-1. ISSN  1568-5608. PMID  28389995. S2CID  254576802.
  11. ^ "Fakhreddin Jamali". International Pharmaceutical Federation.

External links



Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook